REPEAT - AgraFlora Organics Integrates Proprietary Manufacturing Processes for Cannabinoid-Infused Formulations at GMP-Certif...
August 01 2019 - 8:30AM
AgraFlora Organics International
Inc. (“
AgraFlora” or the
“
Company”) (
CSE: AGRA) (Frankfurt:
PU31) (OTCPK: PUFXF), a growth oriented and diversified
international cannabis company, is pleased to provide the following
guidance relating to the integration of its proprietary cannabinoid
formulations library and manufacturing processes at the Company’s
fully operational GMP-certified Toronto, ON facility (the “Toronto
Facility”):
- On-going integration of customized manufacturing equipment at
AgraFlora’s Toronto-based, GMP-certified manufacturing campus:•
Engineered to support AgraFlora’s proprietary micro-diffusion
technologies, thus optimizing solubility and bioavailability for
cannabinoid-infused products;
- AgraFlora’s formulation library has been successfully deployed
at leading dispensaries within Colorado’s legalized recreational
cannabis market;• 99% to 100% accuracy for THC potency results as
reported by a ISO-certified lab in Colorado, USA, far exceeding
domestic standards requiring less than 10% variance;
- Continuous refinement of formulation catalogue, tailored
specifically for the Canadian marketplace, including Health Canada
regulations, humidity, water quality, altitude and barometric
pressures;
- Prototyping of Nicorette-inspired, medicinal-use cannabis
products including flavor enhancement, consistent dosage levels and
compliant packaging;
- AgraFlora’s Nicorette-inspired, medicinal-use cannabis products
will boast the following patented micro-diffusion product
qualities:• Proprietary dual-delivery technology: Advanced patented
processes reduce surface tensions, increase binding of molecules
and enable homogenous mixing;• Rapid sublingual activation:
Optimized absorption methodologies facilitates rapid an onset
within the first 15 minutes of application; and• Metabolism
efficacy: Metabolizes in the liver to create a more lasting
effect
- Design and production of state-of-the-art machinery for the
Company’s array of unique product formulations, devised to achieve
a defendable first mover advantage in the following product
categories:• Gum, gummies, chews, mints, hard candy, pressed
tablets and capsules;• Teas, coffees and protein drinks;•
Pet-centric products;• Skincare lotions; and• Bath bombs.
By way of an exclusive agreement, AgraFlora controls the
Canadian rights to a robust library of cannabinoid product
formulations, equipped with patented micro-diffusion technologies
designed to optimize rapid onset effects and cannabinoid uptake.
Developed by a renowned global formulations provider, boasting over
three decades of experience collaborating with leading consumer
product goods (“CPG”) brands, AgraFlora’s formulation catalogue
will result in a measurable competitive advantage within Canada’s
emerging topicals, edibles and cannabinoid-infused beverage
market.
The Company has engaged a roster of food engineers,
nutritionists and scientists to optimize bioavailability,
consistent dosing protocols and flavouring of its licensed
formulations. AgraFlora will continue to leverage its production
and processing assets, while further activating its downstream
activities by launching cannabinoid-infused beverages, edibles and
personal care products, specifically formulated with patented
micro-diffusion technologies.
AgraFlora’s in-house food science consultancy arm is comprised
of experienced microbiologists, as well as certified bakers trained
by the American Institute of Baking (“AIB”). The AIB is a
100-year-old cornerstone industry authority, which has successfully
instituted food safety, quality management and optimized production
practices for the some of the world’s most prominent food
conglomerates including P&G, Nestlé, Kraft and Heinz.
The Company’s food engineers, nutritionists and scientists have
created numerous turnkey recipes for a variety of Fortune 500
companies; resulting in over US$300 million of attributable sales
revenues. Equipped with 30-years of combined experience within the
competitive CPG food product development space, AgraFlora’s
in-house food science team has developed a portfolio of successful
products for CPG industry leaders such as Dean Foods; the largest
dairy company in America. Most recently, over the past five years,
AgraFlora’s in-house product formulation consultants have pioneered
the scalable formulation and development of shelf stable
THC/CBD-infused edibles within the mature Colorado marketplace.
Already certified with GMP, Organic, Vegan, Fair Trade, and
Kosher certifications, the Toronto Facility is currently undergoing
the appropriate licensing for the forthcoming Health Canada
edibles, topicals and beverages regulations. Outfitted with unique
pharma-grade mixing tanks designed to support highly complex
processes required to create craft quality cold brew coffees/teas,
as well as custom shelf stability enhancing manufacturing lines,
the Company’s Toronto Facility is widely considered one of the most
advanced cannabinoid-infused manufacturing campuses in the
world.
The Company’s robust formulations library will further bolster
AgraFlora’s leading market position as a global cultivation,
processor and distribution leader for cannabinoid-infused products
across both the recreational and medicinal markets.
Brandon Boddy, Chairman and Chief Executive Officer of AgraFlora
stated: “The Company’s Toronto Facility is arguably the industry’s
premier one-stop craft production facility for cannabinoid-infused
food, beverages and therapeutic products. With the Canadian market
primed to embrace formal regulations regarding cannabis edibles and
beverages and legal cannabis in Canada, we are set to capture a
significant proportion of this lucrative marketplace. The market
for cannabis edibles and beverages and legal cannabis in Canada
expected to increase at a 44% CAGR to $5.2 billion over the next 5
years1”.
Further to the Company’s fully subscribed June 25th Delta
Greenhouse Complex Institutional Investor, Industry Analyst and
Media Tour (the “Tour”), AgraFlora is pleased to announce a
high-definition video summary of the Tour has subsequently posted
to the Company’s corporate website for viewing by retail investors
and those interested parties unable to attend. AgraFlora encourages
all current and prospective investors to view the Tour video
summary by following the below stated URL:
- https://agraflora.com/delta-greenhouse-complex-event/
The Company also announces it has granted incentive stock
options to purchase a total of thirty million common shares at an
exercise price of 31 cents per share for a period of five years to
certain directors, officers and consultants, in accordance with the
provisions of its stock option plan.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and
diversified company focused on the international cannabis industry.
It owns an indoor cultivation operation in London, ON and is a
joint venture partner in Propagation Service Canada and its
large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The
Company has a successful record of creating shareholder value and
is actively pursuing other opportunities within the cannabis
industry. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Brandon Boddy Chairman & CEOT: (604) 682-2928
For additional information: |
|
AgraFlora Organics
International Inc. Tim McNultyE: ir@agraflora.com T: (800)
783-6056 |
For French inquiries: Remy
Scalabrini, Maricom Inc.E: rs@maricom.ca T: (888)
585-MARI |
The CSE and Information Service Provider have
not reviewed and does not accept responsibility for the accuracy or
adequacy of this release.
Forward-looking Information Cautionary
Statement
Except for statements of historic fact, this
news release contains certain "forward-looking information" within
the meaning of applicable securities law. Forward-looking
information is frequently characterized by words such as "plan",
"expect", "project", "intend", "believe", "anticipate", "estimate"
and other similar words, or statements that certain events or
conditions "may" or "will" occur. Forward-looking statements are
based on the opinions and estimates at the date the statements are
made, and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those anticipated in the forward-looking statements
including, but not limited to delays or uncertainties with
regulatory approvals, including that of the CSE. There are
uncertainties inherent in forward-looking information, including
factors beyond the Company’s control. There are no assurances that
the business plans for AgraFlora Organics described in this news
release will come into effect on the terms or time frame described
herein. The Company undertakes no obligation to update
forward-looking information if circumstances or management's
estimates or opinions should change except as required by law. The
reader is cautioned not to place undue reliance on forward-looking
statements. Additional information identifying risks and
uncertainties that could affect financial results is contained in
the Company’s filings with Canadian securities regulators, which
are available at www.sedar.com._____________________________
1
https://bdsanalytics.com/new-report-canadian-legal-cannabis-market-projected-to-reach-5-2-billion-by-2024
Agra Ventures (CSE:AGRA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Agra Ventures (CSE:AGRA)
Historical Stock Chart
From Jul 2023 to Jul 2024